Nonalcoholic Steatohepatitis: The Second Leading Indication for Liver Transplantation in the USA

Digestive Diseases and Sciences

Volumn 62, Issue 10, 2017, Pages 2621-2622

  Chedid, Marcio F ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL LIVER DISEASE; CARDIOVASCULAR MORTALITY; CHRONIC LIVER DISEASE; CLINICAL OUTCOME; DYSLIPIDEMIA; EDITORIAL; END STAGE LIVER DISEASE; EXERCISE; GRAFT FAILURE; HEALTHY DIET; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERLIPIDEMIA; LIVER CIRRHOSIS; LIVER INJURY; LIVER TRANSPLANTATION; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; TREATMENT INDICATION; UNITED STATES; VIRAL CLEARANCE; WEIGHT GAIN;

EID: 85028341218     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-017-4724-6     Document Type: Editorial

References (10)

1. Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol. 2013;10:686–690.
2. Kappus M, Abdelmalek M. De novo and recurrence of nonalcoholic steatohepatitis after liver transplantation. Clin Liver Dis. 2017;21:321–335.
3. Cholankeril G, Wong RJ, Hu M, et al. Liver transplantation for nonalcoholic steatohepatitis in the US: Temporal trends and outcomes. Dig Dis Sci. (Epub ahead of print). doi: 10.1007/s10620-017-4684-x.
4. Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology. 2011;141:1249–1253.
5. Chedid MF, Rosen CB, Nyberg SL, Heimbach JK. Excellent long-term patient and graft survival are possible with appropriate use of livers from deceased septuagenarian and octogenarian donors. HPB (Oxford). 2014;16:852–858.
6. Saxena V, Khungar V, Verna EC, et al. Safety and efficacy of current DAA regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV-TARGET study. Hepatology. 2017. doi:10.1002/hep.29258.
7. Doycheva I, Watt KD, Rifai G, et al. Increasing burden of chronic liver disease among adolescents and young adults in the USA: A silent epidemic. Dig Dis Sci. 2017;62:1373–1380.
8. Rowe IA, Webb K, Gunson BK, et al. The impact of disease recurrence on graft survival following liver transplantation: A single centre experience. Transpl Int. 2008;21:459.
9. Pinto AS, Chedid MF, Guerra LT, Cabeleira DD, Kruel CD. Dietary management for dyslipidemia in liver transplant recipients. Arq Bras Cir Dig. 2016;29:246–251.
10. Heimbach JK, Watt KD, Poterucha JJ, et al. Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease. Am J Transpl. 2013;13:363–368.